These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19346090)

  • 41. [Transient elastography for diagnosing liver cirrhosis].
    Erhardt A; Lörke J; Vogt C; Poremba C; Willers R; Sagir A; Häussinger D
    Dtsch Med Wochenschr; 2006 Dec; 131(49):2765-9. PubMed ID: 17136655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementing non-invasive markers for liver fibrosis in clinical practice.
    Sebastiani G; Alberti A
    J Hepatol; 2008 May; 48(5):880-1; author reply 881-3. PubMed ID: 18314216
    [No Abstract]   [Full Text] [Related]  

  • 43. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients.
    Kettaneh A; Marcellin P; Douvin C; Poupon R; Ziol M; Beaugrand M; de Lédinghen V
    J Hepatol; 2007 Apr; 46(4):628-34. PubMed ID: 17258346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-invasive assessment of liver fibrosis: are we ready?
    Castera L; Pinzani M
    Lancet; 2010 Apr; 375(9724):1419-20. PubMed ID: 20417845
    [No Abstract]   [Full Text] [Related]  

  • 45. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
    Pinzani M; Vizzutti F; Arena U; Marra F
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
    Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
    Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of blood panel markers in the diagnosis of hepatic fibrosis].
    Zeng MD; Mao YM; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):163-5. PubMed ID: 18364067
    [No Abstract]   [Full Text] [Related]  

  • 48. [Non-invasive diagnosis of hepatic fibrosis].
    Lu LG; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):210-1. PubMed ID: 16556418
    [No Abstract]   [Full Text] [Related]  

  • 49. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Factors influencing the success rate and stability of transient elastography for liver fibrosis evaluation].
    Li LF; Dai L; Zhang Q; Chen YP; Feng XR; Guo YB; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):595-7. PubMed ID: 18495599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The scope of clinical applications of noninvasive methods for the assessment of liver fibrosis results of orginial studies in a multi-field hospital].
    Pavlov ChS; Glushenkov DV; Konovalova ON; Ivashkin VT
    Klin Med (Mosk); 2009; 87(11):40-5. PubMed ID: 20143565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.
    Tsertsvadze T; Dolmazashvili E; Abutidze A; Sharvadze L; Karchava M
    Georgian Med News; 2008 Dec; (165):38-42. PubMed ID: 19124915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Value of transient elastography in noninvasive assessment in children's hepatic fibrosis].
    Breton E; Bridoux-Henno L; Guyader D; Daniélou H; Jouan H; Beuchée A; Nousbaum JB; Dabadie A
    Arch Pediatr; 2009 Jul; 16(7):1005-10. PubMed ID: 19446446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Liver fibrosis: pathophysiology, diagnosis and treatment].
    Pár A; Pár G
    Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Serologic diagnosis of liver fibrosis].
    Sauerbruch T
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514
    [No Abstract]   [Full Text] [Related]  

  • 58. The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".
    Munteanu M; Ngo Y; Ratziu V; Poynard T
    Gastroenterol Clin Biol; 2009 May; 33(5):387-8; author reply 388-9. PubMed ID: 19372019
    [No Abstract]   [Full Text] [Related]  

  • 59. Noninvasive assessment of liver fibrosis: the need for better validation.
    Tsochatzis EA; Germani G; Hall A; Anousou PM; Dhillon AP; Burroughs AK
    Hepatology; 2011 May; 53(5):1781-2; author reply 1782-3. PubMed ID: 21384400
    [No Abstract]   [Full Text] [Related]  

  • 60. Methods and interest of noninvasive assessment of liver fibrosis are still in debate.
    Degos F; Lebrun L; Perez P; Durand-Zaleski I
    Hepatology; 2011 May; 53(5):1781; author reply 1782-3. PubMed ID: 21384405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.